Dr. Ian Gilham
Research tool provider Horizon Discovery has appointed Dr. Ian Gilham as a non-executive director.
“His commercial and investor relations experience will be highly valuable to the company as we continue to develop as a world-leading translational genomics organization,” said Horizon CEO Dr. Darrin Disley.
Gilham - who has previously been CEO of Axis-Shield and Vice President, Pharmacogenetics and Diagnostics at GSK - is Director of Stowheath, and non-executive chairman of Multiplicom NV and Biosurfit.
